HomeCompareGRCGF vs MRK

GRCGF vs MRK: Dividend Comparison 2026

GRCGF yields 3.53% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GRCGF wins by $944.02M in total portfolio value
10 years
GRCGF
GRCGF
● Live price
3.53%
Share price
$31.85
Annual div
$1.13
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$944.07M
Annual income
$895,388,970.22
Full GRCGF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — GRCGF vs MRK

📍 GRCGF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGRCGFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GRCGF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GRCGF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GRCGF
Annual income on $10K today (after 15% tax)
$300.31/yr
After 10yr DRIP, annual income (after tax)
$761,080,624.69/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, GRCGF beats the other by $761,072,296.28/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GRCGF + MRK for your $10,000?

GRCGF: 50%MRK: 50%
100% MRK50/50100% GRCGF
Portfolio after 10yr
$472.07M
Annual income
$447,699,384.18/yr
Blended yield
94.84%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

GRCGF
No analyst data
Altman Z
2.1
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GRCGF buys
0
MRK buys
0
No recent congressional trades found for GRCGF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGRCGFMRK
Forward yield3.53%2.76%
Annual dividend / share$1.13$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$944.07M$56.8K
Annual income after 10y$895,388,970.22$9,798.13
Total dividends collected$940.54M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: GRCGF vs MRK ($10,000, DRIP)

YearGRCGF PortfolioGRCGF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,407$706.62$11,206$366.19+$201.00GRCGF
2$13,712$1,506.57$12,650$502.35+$1.1KGRCGF
3$18,057$3,385.07$14,407$694.19+$3.6KGRCGF
4$27,653$8,332.17$16,585$967.82+$11.1KGRCGF
5$53,439$23,851.01$19,342$1,363.89+$34.1KGRCGF
6$143,334$86,154.35$22,913$1,947.19+$120.4KGRCGF
7$585,297$431,929.54$27,662$2,823.89+$557.6KGRCGF
8$3,923,012$3,296,743.35$34,159$4,173.35+$3.89MGRCGF
9$45,499,933$41,302,310.91$43,337$6,308.80+$45.46MGRCGF
10$944,073,899$895,388,970.22$56,776$9,798.13+$944.02MGRCGF

GRCGF vs MRK: Complete Analysis 2026

GRCGFStock

Guardian Capital Group Limited, together with its subsidiaries, operates as a diversified financial services company in Canada and internationally. The company operates through Investment management, Wealth management, Corporate activities and investment segments. The Investment management segment provides investment management services provided to clients. The Wealth management segment is involved in investment management and advisory services to high and ultra-high net worth clients, commissions on life insurance products, mutual funds ,and other securities. The Corporate Activities and Investments segment comprises of investment of securities holdings, as well as corporate management and development activities. In addition, the company manages institutional assets for pension plans, broker-dealer third-party platforms, insurance company segregated, exchange traded, and mutual funds, endowment funds, and foundations; and provides private wealth management services to high-net-worth families, foundations, and charities. Further, the company offers banking services for international clients and independent platform for financial advisors to clients. Additionally, the company sells life insurance products, mutual funds, and other securities. Guardian Capital Group Limited was incorporated in 1962 and is headquartered in Toronto, Canada.

Full GRCGF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this GRCGF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GRCGF vs SCHDGRCGF vs JEPIGRCGF vs OGRCGF vs KOGRCGF vs MAINGRCGF vs JNJGRCGF vs ABBVGRCGF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.